Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas von Yu, Ming, Carter, Kelly T, Baker, Kelsey K, Redman, Mary W, Wang, Ting, Vickers, Kathy, Li, Christopher I, Cohen, Stacey A, Krane, Mukta, Ose, Jennifer, Gigic, Biljana, Figueiredo, Jane C, Toriola, Adetunji T, Siegel, Erin M, Shibata, David, Schneider, Martin, Ulrich, Cornelia M, Dzubinski, Lynda A, Schoen, Robert E, Grady, William M

Volltext

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study von KIMURA, Takashi, MCKOLANIS, John R, DZUBINSKI, Lynda A, ISLAM, Kazi, POTTER, Douglas M, SALAZAR, Andres M, SCHOEN, Robert E, FINN, Olivera J

Volltext

Abstract 477: Elevated EVL methylation level in the normal colon mucosa is a potential risk biomarker for developing metachronous polyps von Yu, Ming, Wang, Ting, Carter, Kelly T., Baker, Kelsey, Redman, Mary W., Vickers, Kathy, Dzubinski, Lynda Ann, Schoen, Robert E., Grady, William M.

Volltext

Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma von Schoen, Robert E, Boardman, Lisa A, Cruz-Correa, Marcia, Bansal, Ajay, Kastenberg, David, Hur, Chin, Dzubinski, Lynda, Kaufman, Sharon F, Rodriguez, Luz M, Richmond, Ellen, Umar, Asad, Szabo, Eva, Salazar, Andres, McKolanis, John, Beatty, Pamela, Pai, Reetesh K, Singhi, Aatur D, Jacqueline, Camille M, Bao, Riyue, Diergaarde, Brenda, McMurray, Ryan P, Strand, Carrie, Foster, Nathan R, Zahrieh, David M, Limburg, Paul J, Finn, Olivera J

Volltext

Design and utilization of the colorectal and pancreatic neoplasm virtual biorepository: An early detection research network initiative von Amin, Waqas, Singh, Harpreet, Dzubinski, Lynda Ann, Schoen, Robert E., Parwani, Anil V.

Volltext

Abstract LB-305: Randomized, double-blind, placebo-controlled immunoprevention trial with MUC1 vaccine in patients with newly diagnosed advanced adenomas von Schoen, Robert E., Boardman, Lisa A., Cruz-Correa, Marcia, Bansal, Ajay, Beatty, Pamela L., Kastenberg, David, Hur, Chin, Dzubinski, Lynda, Rodriguez, Luz, Salazar, Andres, McKolanis, John, Seisler, Drew, Foster, Nathan R., Polley, May-Yin, Limburg, Paul J., Finn, Olivera J.

Volltext

Abstract CT236: Randomized, double-blind, placebo-controlled trial of preventative MUC1 vaccine in patients with newly diagnosed advanced adenomas: Results from one-year booster von Finn, Olivera J., Boardman, Lisa, Cruz-Correa, Marcia, Bansal, Ajay, Kastenberg, David, Hurr, Chin, Kaufman, Sharon, Akerley, Colleen, Dzubinski, Lynda, Felt, April, Fursa, Karrie, Rodriguez, L.M., Richmond, Ellen, Umar, Asad, Szabo, Eva, McKolanis, John, McMurray, Ryan, Foster, Nathan, Salazar, Andres, Limburg, Paul, Schoen, Robert

Volltext

Mo1987 - Randomized, Double-Blind, Placebo-Controlled Immunoprevention Trial with MUC1 Vaccine in Patients with Newly Diagnosed Advanced Adenomas von Schoen, Robert E., Boardman, Lisa A., Cruz-Correa, Marcia R., Bansal, Ajay, Kastenberg, David M., Hur, Chin, Dzubinski, Lynda, Rodriguez, L.M., Salazar, Andres, McKolanis, John, Beatty, Pamela, Pai, Reet, Seisler, Drew, Foster, Nathan R., Polley, Mei-Yin, Limburg, Paul, Finn, Olivera J.

Volltext